Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
240.00    5.00 (2.13%)
Bid:
235.00
Ask:
245.00
Spread: 10.00 (4.255%)
Market Cap: £86.30m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Trading Statement

23 Jul 2020 07:00

RNS Number : 8120T
Alumasc Group PLC
23 July 2020
 

23 July 2020

 

THE ALUMASC GROUP PLC

("ALUMASC")

Trading Statement

June sales significantly ahead of internal forecasts

Alumasc, the premium building products, systems and solutions group, provides the following update on trading. The financial year to 30 June 2020 ended with improving trading, with sales in the second half of May and during June significantly ahead of internal forecasts made earlier in the pandemic. Revenue for the year ended 30 June 2020 is now expected to be approximately £76m a decrease of c.16% on the previous year almost entirely as a result of the COVID-19 lockdown, with the bulk of the impact felt during late March, April and early May.

Our primary focus continues to be the safety and wellbeing of our employees, suppliers and customers. Alumasc's health and safety practices follow UK Government guidelines at all our sites in terms of being COVID-19 secure.

FY2020 and current trading

Despite the adverse impact of the reduced revenue, profitability has benefitted from internal initiatives to reduce costs, as advised in previous announcements. Prior to the outbreak of the COVID-19 pandemic Alumasc was already in the process of implementing a cost saving programme focussed on realising synergies available following the acquisition of Wade, together with other operational efficiencies and improvements. Subsequent to the lockdown this process was accelerated, and further actions were taken, including the reduction of all non-essential expenditure, a freeze on all non-essential recruitment and a redoubling of our efforts around working capital resulting. All actions combined generated total cost savings of £2.4m compared to the prior financial year.

Encouragingly, improved levels of trading have continued into July, and all sites and manufacturing locations are now fully operational. Each location has implemented appropriate social distancing requirements without any loss of productivity.

Order intake has matched the general pick-up in construction activity and inquiry levels continue to be strong both in the UK and from the Group's targeted overseas markets. There has also been increased interest in the Group's premium and sustainable product range, which is well positioned to benefit from the UK Government's announced planned expenditure on a wide range of infrastructure and public sector construction projects.

Balance sheet and liquidity

As at 30 June 2020, the Group had net debt of £4.3m (compared to £5.1m at 30 June 2019). This is comfortably ahead of management's expectations as at the start of the final quarter once lockdown started, with leverage and interest cover metrics at 30 June 2020 well within covenant limits, reflecting the encouraging recent trading performance and effective working capital focus. The Company has also benefitted from a VAT deferral.

Group liquidity is strong with £15.7m cash held at 30 June 2020, following the draw down of the RCF. The Group's total bank facilities are £24m, comprising the committed RCF of £20m and overdraft facilities of £4m. Hence the Group had headroom of £19.7m against its total banking facilities at 30 June 2020.

Outlook

Trading has been better than management expected at the outset of COVID-19 and continues to show an improving trend, despite the challenging environment.

Alumasc's cost savings programme, liquidity management, strong balance sheet and improved commercial positioning underpin a robust platform that should greatly benefit the Group into a broader economic recovery when it materialises. Alumasc's primary aim is to manage the long-term sustainability of the business and to focus on its key strategic objectives, growing revenues faster than the UK construction market and being a supplier of sustainable building products.

Alumasc expects to release its preliminary results in September 2020. Given the uncertain economic backdrop, financial guidance remains suspended at present, and the Board will provide an update in September 2020.

 

This announcement contains inside information for the purposes of Market Abuse Regulation (Regulation (EU) No. 596/2014). The person responsible for making this announcement on behalf of the Company is Helen Ashton, Group Company Secretary.

 

Enquiries:

 

Paul Hooper, CEO

Helen Ashton, Group Company Secretary

 

+ 44 (0) 1536 383844

+ 44 (0) 1536 383812

 

Peel Hunt (Broker)

Mike Bell + 44 (0) 207 418 8831

Ed Allsopp

 

finnCap (NOMAD)

Julian Blunt + 44 (0) 207 220 0561

Camarco

Ginny Pulbrook + 44 (0) 203 757 4992

Tom Huddart + 44 (0) 203 757 4991

Email: alumasc@camarco.co.uk

 

Notes to Editors:

Alumasc is a UK-based supplier of premium building products, systems and solutions. Almost 80% of group sales are driven by building regulations and specifications (architects and structural engineers) because of the performance characteristics offered.

 

The Group has three business segments with strong positions and brands in their individual markets. The three segments are: Building Envelope; Water Management; and Housebuilding Products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFVRDFIFFII
Date   Source Headline
6th May 20261:21 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSDirector Dealings
20th Apr 20262:37 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ3 Trading Update
1st Apr 20267:00 amRNSConfirmation of CEO appointment
9th Feb 20267:00 amRNS-RMelloMonday Investor Webinar
3rd Feb 20267:00 amRNSInterim Results
15th Jan 20267:00 amRNSDirectorate change
10th Dec 20259:36 amRNSNotice of Half Year Results
21st Nov 20252:17 pmRNSDirector/PDMR Shareholding
7th Nov 202511:22 amRNSDirector/PDMR Shareholding
5th Nov 20252:50 pmRNSDirector/PDMR Shareholding
4th Nov 202511:03 amRNSDirector/PDMR Shareholding
24th Oct 20251:52 pmRNSResult of AGM
24th Oct 20257:00 amRNSAGM Trading Update
23rd Sep 20257:00 amRNSCEO Retirement & 2025 AGM Notice & Annual Accounts
2nd Sep 20257:00 amRNSFinal Results - Unaudited
21st Jul 20257:00 amRNSNotice of FY Results and Investor Presentation
15th Jul 20257:00 amRNSFull Year Trading Update
11th Jun 20253:46 pmRNSDirector/PDMR Shareholding
27th May 20257:00 amRNSAppointment of Non-executive Director
4th Apr 20257:00 amRNS-ROpening new Wade/Gatic building extension
21st Mar 20257:00 amRNSAppointment of Joint Broker
12th Mar 202511:15 amRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNSHalf-year Results
27th Nov 202412:22 pmRNSNotice of Half Year Results
6th Nov 20241:40 pmRNSDirector/PDMR Shareholding
5th Nov 20248:00 amRNSDirector/PDMR Shareholding
1st Nov 202411:15 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
24th Oct 20241:38 pmRNSResult of AGM
24th Oct 20247:00 amRNSAGM Trading Update
23rd Oct 202412:53 pmRNSDirector/PDMR Shareholding
10th Oct 20247:00 amRNSNotice of Capital Markets Event
4th Oct 20247:00 amRNSDirectorate Change
20th Sep 20242:15 pmRNSNotice of AGM
18th Sep 20242:32 pmRNSDirector/PDMR Shareholding
3rd Sep 20247:00 amRNSFinal Results
25th Jul 20248:00 amRNSNotice of Results
18th Jul 20247:00 amRNSFull Year Trading Update
25th Apr 20249:38 amRNSHolding(s) in Company
27th Feb 202412:31 pmRNSDirector/PDMR Shareholding
14th Feb 20241:01 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSInterim results
11th Jan 20247:00 amRNSNotice of Interim Results
3rd Jan 202412:52 pmRNSDirector/PDMR Shareholding
19th Dec 20239:50 amRNSDirector/PDMR Shareholding
18th Dec 20233:17 pmRNSDirector/PDMR Shareholding
18th Dec 20231:23 pmRNSDirector/PDMR Shareholding
18th Dec 20231:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.